Drug-drug interactions of antibiotics and psychotropic medication

被引:0
|
作者
Joos, AAB [1 ]
机构
[1] Univ Ulm, Zentrum Psychiat Weissenau, D-89069 Ulm, Germany
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
By and large, pharmacokinetic interactions are described: macrolide antibiotics, isoniazid, ciprofloxacin and ampicillin can lead to toxic concentrations of psychotropic drugs, while rifampicin causes subtherapeutic levels. Vice versa, carbamazepine might induce subtherapeutic plasma concentrations of doxycycline. These interactions are caused by inhibition or induction of the hepatic cytochrome P450 enzyme system. Case reports suggest lithium intoxication through concomitant use of tetracycline, metronidazol and spectinomycin, which is contradicted by animal studies. Clinical symptoms depend on the therapeutic index of a given drug, e.g. toxic and subtherapeutic levels are described for clozapine but not for haloperidol. No relevant pharmacodynamic drug-drug interactions are described, although, the author emphasises psychiatric side effects of macrolide antibiotics, isoniazid, beta-lactam antibiotics and fluoroquinolones. On the whole, drug-drug interactions of antibiotics and psychotropics seem rare and usually benign, though more subtle interactions might be overlooked.
引用
收藏
页码:57 / 60
页数:4
相关论文
共 50 条
  • [21] The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review
    Cattaneo, Dario
    Gervasoni, Cristina
    Corona, Alberto
    ANTIBIOTICS-BASEL, 2022, 11 (10):
  • [22] Warnings for drug-drug interactions in consumer medication information provided by community pharmacies
    Panich, Jennifer
    Gooden, Andrea
    Shirazi, F. Mazda
    Malone, Daniel C.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2019, 59 (01) : 35 - 42
  • [23] EVALUATION OF A WIRELESS HANDHELD MEDICATION MANAGEMENT PROGRAM IN THE PREVENTION OF DRUG-DRUG INTERACTIONS
    Saverno, K.
    Malone, D. C.
    VALUE IN HEALTH, 2009, 12 (03) : A96 - A96
  • [24] COCAINE DRUG-DRUG INTERACTIONS
    ROSEN, EH
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1992, 12 (06) : 445 - 445
  • [25] NOACs: drug-drug interactions
    Hudzik, Bartosz
    Lekston, Andrzej
    Gasior, Mariusz
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2016, 188 (05) : 369 - 369
  • [26] Drug-drug interactions in the elderly
    Björkman, IK
    Fastbom, J
    Schmidt, IK
    Bernsten, CB
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (11) : 1675 - 1681
  • [27] KINETICS OF DRUG-DRUG INTERACTIONS
    ROWLAND, M
    MATIN, SB
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (06): : 553 - 567
  • [28] KINETICS OF DRUG-DRUG INTERACTIONS
    AARONS, L
    PHARMACOLOGY & THERAPEUTICS, 1981, 14 (03) : 321 - 344
  • [29] Avoiding Drug-Drug Interactions
    Astrand, Bengt
    CHEMOTHERAPY, 2009, 55 (04) : 215 - 220
  • [30] DRUG-DRUG INTERACTIONS IN PERSPECTIVE
    HANSTEN, PD
    NORTHWEST MEDICAL JOURNAL, 1974, 1 (03): : 43 - 45